Prescription drug abuse: FDA and SAMHSA join forces.
Meadows
Michelle
M
D002047:Buprenorphine / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D006801:Humans; D009292:Narcotic Antagonists / Q000627:therapeutic use; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D019966:Substance-Related Disorders / Q000517:prevention & control* / Q000534:rehabilitation; D014481:United States; D014486:United States Food and Drug Administration
D003692:Delayed-Action Preparations; D009292:Narcotic Antagonists; D004364:Pharmaceutical Preparations; D002047:Buprenorphine